Page last updated: 2024-08-23

gusperimus and Lymphoma

gusperimus has been researched along with Lymphoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inagaki, J; Kimura, I; Majima, H; Masaoka, T; Niitani, H; Oguro, M; Ohno, R; Sanpi, K; Suzuoki, Y; Tamura, K1
Inuma, H; Ishizuka, M; Kawada, M; Masuda, T; Someno, T; Takeuchi, T1
Ishizuka, M; Kawada, M; Masuda, T; Takeuchi, T1

Trials

1 trial(s) available for gusperimus and Lymphoma

ArticleYear
Phase I study of NKT-01.
    Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Dose-Response Relationship, Drug; Female; Guanidines; Hemoglobins; Humans; Leukemia; Leukocyte Count; Leukopenia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neoplasms; Platelet Count; Regression Analysis

1995

Other Studies

2 other study(ies) available for gusperimus and Lymphoma

ArticleYear
The long-lasting antiproliferative effect of 15-deoxyspergualin through its spermidine moiety.
    The Journal of antibiotics, 2000, Volume: 53, Issue:7

    Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Guanidines; Inhibitory Concentration 50; Lymphoma; Mice; Structure-Activity Relationship; Tumor Cells, Cultured

2000
15-Deoxyspergualin inhibits Akt kinase activation and phosphatidylcholine synthesis.
    The Journal of biological chemistry, 2002, Aug-02, Volume: 277, Issue:31

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Division; Enzyme Activation; Female; Guanidines; Humans; K562 Cells; Kinetics; Lymphoma; Mice; Mice, Inbred C57BL; Phosphatidylcholines; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases; Time Factors; Tumor Cells, Cultured

2002